These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22781427)

  • 41. Mediation analysis via potential outcomes models.
    Albert JM
    Stat Med; 2008 Apr; 27(8):1282-304. PubMed ID: 17691077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.
    Bieler GS; Brown GG; Williams RL; Brogan DJ
    Am J Epidemiol; 2010 Mar; 171(5):618-23. PubMed ID: 20133516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Directed acyclic graphs (DAGs) - the application of causal diagrams in epidemiology].
    Schipf S; Knüppel S; Hardt J; Stang A
    Gesundheitswesen; 2011 Dec; 73(12):888-92. PubMed ID: 22193898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marginal structural models for estimating principal stratum direct effects under the monotonicity assumption.
    Chiba Y
    Biom J; 2011 Nov; 53(6):1025-34. PubMed ID: 22020774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding Interventional Effects: A More Natural Approach to Mediation Analysis?
    Moreno-Betancur M; Carlin JB
    Epidemiology; 2018 Sep; 29(5):614-617. PubMed ID: 29864082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect decomposition in the presence of an exposure-induced mediator-outcome confounder.
    Vanderweele TJ; Vansteelandt S; Robins JM
    Epidemiology; 2014 Mar; 25(2):300-6. PubMed ID: 24487213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A set of SAS macros for calculating and displaying adjusted odds ratios (with confidence intervals) for continuous covariates in logistic B-spline regression models.
    Gregory M; Ulmer H; Pfeiffer KP; Lang S; Strasak AM
    Comput Methods Programs Biomed; 2008 Oct; 92(1):109-14. PubMed ID: 18603325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An introduction to latent growth curve modelling for longitudinal continuous data in dental research.
    Tu YK; D'Aiuto F; Baelum V; Gilthorpe MS
    Eur J Oral Sci; 2009 Aug; 117(4):343-50. PubMed ID: 19627343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal Mediation Analysis Using Natural Effect Models.
    Mittinty MN; Vansteelandt S
    Am J Epidemiol; 2020 Nov; 189(11):1427-1435. PubMed ID: 32458988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statistical methods and tool for cut point analysis in immunogenicity assays.
    Zhang L; Zhang JJ; Kubiak RJ; Yang H
    J Immunol Methods; 2013 Mar; 389(1-2):79-87. PubMed ID: 23305975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Causal inference in occupational epidemiology: accounting for the healthy worker effect by using structural nested models.
    Naimi AI; Richardson DB; Cole SR
    Am J Epidemiol; 2013 Dec; 178(12):1681-6. PubMed ID: 24077092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defining causal mediation with a longitudinal mediator and a survival outcome.
    Didelez V
    Lifetime Data Anal; 2019 Oct; 25(4):593-610. PubMed ID: 30218418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mediation Analysis for Censored Survival Data Under an Accelerated Failure Time Model.
    Fulcher IR; Tchetgen Tchetgen EJ; Williams PL
    Epidemiology; 2017 Sep; 28(5):660-666. PubMed ID: 28574921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comment on Pearl: Practical implications of theoretical results for causal mediation analysis.
    Imai K; Keele L; Tingley D; Yamamoto T
    Psychol Methods; 2014 Dec; 19(4):482-7. PubMed ID: 25486116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into the Cross-world Independence Assumption of Causal Mediation Analysis.
    Andrews RM; Didelez V
    Epidemiology; 2021 Mar; 32(2):209-219. PubMed ID: 33512846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A test for the correct specification of marginal structural models.
    Sall A; Aubé K; Trudel X; Brisson C; Talbot D
    Stat Med; 2019 Jul; 38(17):3168-3183. PubMed ID: 30856294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invited commentary: boundless science--putting natural direct and indirect effects in a clearer empirical context.
    Naimi AI
    Am J Epidemiol; 2015 Jul; 182(2):109-14. PubMed ID: 25944884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inverse odds ratio-weighted estimation for causal mediation analysis.
    Tchetgen Tchetgen EJ
    Stat Med; 2013 Nov; 32(26):4567-80. PubMed ID: 23744517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tests of marginal homogeneity and special cases.
    Dunnigan K
    Pharm Stat; 2013; 12(4):213-6. PubMed ID: 23776034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of natural direct effects when a confounder of the mediator is directly affected by exposure.
    Tchetgen Tchetgen EJ; Vanderweele TJ
    Epidemiology; 2014 Mar; 25(2):282-91. PubMed ID: 24487211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.